Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
China · Delayed Price · Currency is CNY 5.05
-0.01 (-0.20%)
May 8, 2026, 3:00 PM CST
SHA:600998 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2,173 | 2,410 | 2,507 | 2,174 | 2,085 | 2,448 |
Depreciation & Amortization | 836.37 | 836.37 | 804.58 | 774.94 | 736.28 | 656.81 |
Other Amortization | 59.82 | 59.82 | 101.93 | 41.51 | 46.26 | 46.74 |
Loss (Gain) From Sale of Assets | 244.27 | 244.27 | 424.2 | -6.92 | -48.23 | -6.72 |
Asset Writedown & Restructuring Costs | 95.54 | 95.54 | 12.49 | 2.99 | 2.56 | 2.35 |
Loss (Gain) From Sale of Investments | -1,000 | -1,000 | -1,192 | 37.4 | -308.25 | -1,456 |
Provision & Write-off of Bad Debts | - | - | 24.13 | 131.87 | 160.56 | 201.32 |
Other Operating Activities | 1,648 | 1,107 | 1,158 | 1,098 | 1,642 | 1,369 |
Change in Accounts Receivable | -2,166 | -2,166 | -4,615 | 1,476 | -4,446 | -2,971 |
Change in Inventory | -7,435 | -7,435 | -2,671 | -2,828 | -1,633 | -720.4 |
Change in Accounts Payable | 9,362 | 9,362 | 6,680 | 1,880 | 5,933 | 3,724 |
Change in Other Net Operating Assets | 50.93 | 50.93 | 87.14 | 104.4 | 94.36 | - |
Operating Cash Flow | 3,745 | 3,441 | 3,083 | 4,748 | 3,986 | 3,459 |
Operating Cash Flow Growth | 9.88% | 11.62% | -35.07% | 19.10% | 15.24% | 0.44% |
Capital Expenditures | -1,313 | -1,402 | -975.42 | -1,049 | -1,243 | -1,386 |
Sale of Property, Plant & Equipment | 21.71 | 22.8 | 22.82 | 163.42 | 160.85 | 171.49 |
Cash Acquisitions | -575.21 | -575.95 | -34.55 | -79.5 | -286.29 | -28.58 |
Divestitures | 313.81 | 1,985 | 743.51 | 47.18 | 126.75 | -22.72 |
Investment in Securities | -296.89 | -805.36 | -4,478 | -774.57 | 2,805 | -1,382 |
Other Investing Activities | -331.99 | 607.21 | 3,130 | 331.16 | -75.28 | 105.3 |
Investing Cash Flow | -2,182 | -167.97 | -1,592 | -1,361 | 1,488 | -2,543 |
Short-Term Debt Issued | - | - | - | - | 3,280 | 3,311 |
Long-Term Debt Issued | - | 20,240 | 17,037 | 17,772 | 19,748 | 18,467 |
Total Debt Issued | 22,174 | 20,240 | 17,037 | 17,772 | 23,028 | 21,777 |
Short-Term Debt Repaid | - | - | -2,864 | -4,251 | -1,582 | -1,004 |
Long-Term Debt Repaid | - | -19,588 | -18,711 | -18,122 | -23,295 | -20,258 |
Total Debt Repaid | -19,583 | -19,588 | -21,575 | -22,373 | -24,877 | -21,263 |
Net Debt Issued (Repaid) | 2,591 | 651.82 | -4,538 | -4,601 | -1,849 | 514.42 |
Issuance of Common Stock | - | - | 1,776 | 461.59 | 195.35 | 143.68 |
Repurchase of Common Stock | - | - | -268.15 | - | -425.76 | -0.11 |
Common Dividends Paid | -1,463 | -1,479 | -1,554 | -1,635 | -1,388 | -1,682 |
Other Financing Activities | -1,555 | -1,659 | 2,084 | 5,537 | -1,433 | -993.65 |
Financing Cash Flow | -426.96 | -2,487 | -2,500 | -2,237 | -4,901 | -2,017 |
Foreign Exchange Rate Adjustments | -2.08 | -2.04 | 0.16 | -1.01 | 9.6 | -3.5 |
Net Cash Flow | 1,134 | 783.76 | -1,009 | 1,149 | 582.99 | -1,105 |
Free Cash Flow | 2,432 | 2,039 | 2,107 | 3,699 | 2,743 | 2,073 |
Free Cash Flow Growth | 9.53% | -3.25% | -43.04% | 34.86% | 32.32% | 4.33% |
Free Cash Flow Margin | 1.48% | 1.26% | 1.39% | 2.46% | 1.95% | 1.69% |
Free Cash Flow Per Share | 0.47 | 0.40 | 0.42 | 0.73 | 0.52 | 0.40 |
Cash Income Tax Paid | 2,598 | 2,935 | 2,884 | 3,019 | 2,571 | 2,295 |
Levered Free Cash Flow | 1,438 | 344.42 | 1,393 | 1,290 | 2,962 | 2,729 |
Unlevered Free Cash Flow | 1,438 | 344.42 | 2,195 | 2,113 | 3,725 | 3,445 |
Change in Working Capital | -311.2 | -311.2 | -758.04 | 494.08 | -329.57 | 197.67 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.